期刊文献+

PTX与LFP方案治疗晚期食管癌的临床观察 被引量:2

The clinical effection of the treament of PTX and LFP in late esophagus carcinoma
下载PDF
导出
摘要 目的观察紫杉醇(PTX)联合LFP方案治疗晚期食管癌的近期疗效及毒反应。方法46例晚期食管癌采用PTX+LFP方案,PTX按周剂量给药,即PTX80mg/m2,静脉滴注,1次/周,连续2周,LFP方案常规给药。21d为1个周期,至少完成两周期评价。结果全组46例均可评价疗效,28例初治有效率67.8%,18例复治有效率50.0%,总有效率60.8%,主要毒副作用为骨髓抑制。结论PLFP方案治疗晚期食管癌疗效较好,毒反应可以耐受,可作为治疗晚期食管癌的有效方案。 Objective To investigate the short-term effects and the side-effects in late carcinoma of the esophagus in the combined treatment of PTX and LFP. Methods 46 cases were treated with PTX and LFP ; PTX was given weekly,is PTX80 mg/m^2 ,iv gtt qw two weeks,and LFP was treated regularly. 21 days were included in one course of treatment and two courses must be completed at least. Results Curative effects could be evaluated by all the 46 cases. The curative rate of the 28 cases who were treated first time is 67.8% ,and that of the 18 cases who were retreated is 50. 0%. The overall effective rate is 60. 8% ,and the main side-effect is Myelosuppression. Conclusion PLFP is more effective to Esophagus Carcinoma of advanced stage and the side- effects are acceptable to the patients. So it can be an effective option to the Esophagus Carcinoma patients of advanced stage.
出处 《中国实用医药》 2008年第18期55-56,共2页 China Practical Medicine
关键词 紫杉醇(PTX) 食管癌 化疗 PTX Carcinoma of the esophagus Chemotherapy
  • 相关文献

参考文献6

  • 1[1]Ajani JA.Contribution of chemotherapy in the treatment of carcinoma of the esophagus:results and commentary.semin oncol,1994,21(4):474-481.
  • 2王志良 樊青霞 王瑞林 等.100例晚期食管癌联合化疗疗效分析[J].癌症,1995,5(4):290-290.
  • 3[3]Li Y,Polis B,Cegelski l,et al.Conformation of microtubulebound paclitaxel determined by fluorescence spectroscopy and redor nmr.biochemistry,2000,39(2):281-291.
  • 4[4]Polee MB,Esken FA,Burg ME,et al.PhaseII study of biweekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer.Br Cancer,2002,86(5):669-673.
  • 5郭仁宏,张全安,唐桂棣,潘良熹,黄新恩,冯继锋.周剂量紫杉醇联合LFP方案治疗晚期食管癌的临床研究[J].临床肿瘤学杂志,2006,11(11):825-827. 被引量:5
  • 6肖毅军,陈小兵,罗素霞.紫杉醇每周疗法联合LFP方案治疗34例晚期食管癌[J].肿瘤学杂志,2004,10(6):422-424. 被引量:9

二级参考文献15

  • 1肖毅军,陈小兵,罗素霞.紫杉醇每周疗法联合LFP方案治疗34例晚期食管癌[J].肿瘤学杂志,2004,10(6):422-424. 被引量:9
  • 2中国肿瘤防治研究办公室卫生部统计信息中心.中国试点市、县恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002.28-34.
  • 3[1]Kingston DG, Samaranayake G, Lvey CA. The chemistry of Taxol, a clinically useful anticancer agent [J]. J Nat Prod, 1990, 53(1): 1-5.
  • 4[2]Klauber N, Parangi S, Flynn E, et al. Inhibition of angio genesis and breast cancer in mice by the microtubule inhibitors 2-Methoxyestradiol and paclitaxel [J]. Cancer Res, 1997, 57(1): 81-84.
  • 5[3]Ajani JA, Ilson DH, Dangherty K, et al. Activity of taxol in patients with sqamous cell carcinoma and adenocarcinoma of the esophagus [J]. J Natl Cancer Inst, 1994, 86 (4): 1086-1090.
  • 6[4]Ajani JA. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary[J]. J Semin Oncol, 1994, 21(4): 474-479.
  • 7[5]Ilson DH, Ajani J, Bhalla K, et al. Phase Ⅱ trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus [J]. J Clin Oncol, 1998, 16(5):1826-1831.
  • 8[6]Murad AM, Tinoeo LA, Guimares RC, et al. Paclitaxel (T) plus 5-fluorouracil (5-Fu): a novel and very active regimen for advanced gastric cancer (Agastric cancer). A phase Ⅱ trial [J]. Proc Annu Meet Am Soe Clin Oncol,1997, 16(A): 1063-1065.
  • 9[7]Perej EA, Vogel CL, Irwin DH, et al. Multicenter phase Ⅱ trial of weekly paclitaxel in women with metastasis breast cancer [J]. J Clin Oncol, 2001, 19(22): 4216-4220.
  • 10[8]Murad AM. Phase Ⅱ trial of combination of paelitaxel and 5-Fluorouracil in the treatment of advanced gastric cancer [J]. South Am J Cancer, 1998, 2(1): 35-39.

共引文献14

同被引文献31

  • 1王海波,吴式琇,黄庆科.中西医疗效评价方法在进展期胃癌中的比较研究[J].浙江中医药大学学报,2011,35(5):673-675. 被引量:7
  • 2Indran IR, Tufo G, Pervaiz S,et al. Recent advances in apopto-sis,mitochondria and drug resistance in cancer cells [ J ]. Bio-chim Biophys Acta,2011,1807(6) :735 -745.
  • 3Park JE, Woo SR, Kang CM ,et al. Paclitaxel stimulates chromo-somal fusion and instability in cells with dysfunctional telomeres :Implication in multinucleation and chemosensitization [ J ]. Bio-chem and Biophys Res Commun,2011 ,404(2) :615 -621.
  • 4Demidenko Z, Kalurupalle S, Hanko C,et al. Mechanism of gl-like arrest by low concentrations of paclitaxel : Next cell cyclep53-dependent arrest with sub gl DNA content mediated by pro-longed mitosis [ J]. Oncogene, 2008 ,27(32) :4402 -4410.
  • 5Eum KH, Lee M. Crosstalk between autophagy and apoptosis inthe regulation of paclitaxel-induced cell death in v-ha-ras-trans-formed fibroblasts[ J]. Mol Cell Biochem,2011,348( 1-2) :61 -68.
  • 6Jordan MA,Wilson L. Microtubules as a target for anticancerdrugs [ J ]. Nat Rev Cancer, 2004,4(4) :253 -265.
  • 7Kang HY,Shim D,Kang SS,et al. Protein kinase B inhibits en-dostatin-induced apoptosis in HUVECs[ J]. J Biochem Mol Biol,2006,39(1) :97.
  • 8Yuan S, Fu Y, Wang X,et al. Voltage-dependent anion channel1is involved in endostatin-induced endothelial cell apoptosis [ J ].FASEB J,2008,22(8) :2809 -2820.
  • 9Hou Q, Cymbalyuk E, Hsu SC,et al. Apoptosis modulatory ac-tivities of transiently expressed bcl-2: Roles in cytochrome c re-lease and bax regulation [ J ]. Apoptosis,2003 , 8 (6 ):617-629.
  • 10Lin DC, Du XL, Wang MR. Protein alterations in escc and clini-cal implications: A review[ J]. Dis Esophagus,2009 ,22 ( 1):9-20.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部